S100B
S100B (S100 calcium binding protein B, also known as S100beta) is a small zinc- and calcium-binding protein of the S100 family, highly expressed in astrocytes and among the most abundant soluble proteins in brain. It acts as a neurotrophic factor and regulates proteins through calcium-dependent interactions. Browse Assay Genie's current range of S100B research reagents below, or read on for the biology behind the target.
S100B is a small zinc- and calcium-binding protein that is highly expressed in astrocytes and is one of the most abundant soluble proteins in brain. Each monomer has distinct binding sites of differing affinity for calcium and zinc. S100B binds calcium weakly but zinc very tightly, and physiological concentrations of potassium antagonise the binding of both divalent cations, especially at high-affinity calcium sites. Through calcium-dependent interactions with other proteins, such as TPR-containing proteins, it may modulate their activity across many physiological processes.
S100B acts as a neurotrophic factor that promotes astrocytosis and axonal proliferation. It also acts as an adipocyte-derived neurotrophic factor that promotes sympathetic innervation of thermogenic adipose tissue. It binds to and initiates activation of the kinase STK38 by releasing autoinhibitory intramolecular interactions. After myocardial infarction, its interaction with AGER may contribute to myocyte apoptosis by activating ERK1/2 and p53/TP53 signalling. It could also assist ATAD3A cytoplasmic processing, preventing aggregation and favouring mitochondrial localisation. NCBI Gene summarises further proposed roles in neurite extension, melanoma cell proliferation, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation and inhibition of microtubule assembly.
The S100B gene encodes a member of the S100 family, which contains two EF-hand calcium-binding motifs. S100 proteins are found in the cytoplasm and/or nucleus of many cell types and take part in processes such as cell cycle progression and differentiation; S100B is also found in the secreted fraction. Unlike the S100 gene cluster on chromosome 1q21, this gene lies on chromosome 21. Chromosomal rearrangements and altered expression have been implicated in Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma and type I diabetes. The previous HGNC name was S100 calcium binding protein, beta (neural).
S100B is highly expressed in astrocytes and acts as a neurotrophic factor promoting astrocytosis and axonal proliferation.
Altered S100B expression has been implicated in Alzheimer's disease, Down's syndrome, epilepsy and amyotrophic lateral sclerosis.
Distinct calcium and zinc binding sites on each monomer make S100B a model for calcium-dependent regulation of target proteins.
S100B has been linked to melanoma cell proliferation, type I diabetes and sympathetic innervation of thermogenic adipose tissue.
S100B is a zinc- and calcium-binding protein that acts as a neurotrophic factor, promoting astrocytosis and axonal proliferation. It activates STK38, interacts with AGER and may regulate TPR-containing proteins in a calcium-dependent manner. It can also be secreted from cells.
S100B is also called S100beta, and its full HGNC name is S100 calcium binding protein B. Its previous name was S100 calcium binding protein, beta (neural). UniProt lists the protein as Protein S100-B, a member of the S-100 family.
Mouse and rat both have an S100b ortholog. In humans, altered expression or rearrangements of the gene have been implicated in Alzheimer's disease, Down's syndrome, epilepsy, ALS, melanoma and type I diabetes. Check the datasheet of any product for its validated reactivity.
Other S100 family members, binding partners and astrocyte markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04271; product specifications from Assay Genie datasheets.